This inventor holds 2 USPTO granted patents. Top assignees: Toyo Jozo Kabushiki Kaisha, Kumiai Chemical Industry Co., Ltd., Kumiai Kagaku Kogyo Kabushiki Kaisha. Active years: 1985-1986.
Company Filing History:
2 out of 95 
1 out of 216 
1 out of 1 Years Active: 1985-1986
Title: Katsuo Anma: Innovator in Pharmaceutical Chemistry
Introduction
Katsuo Anma is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with anti-inflammatory properties. His work has led to the filing of multiple patents, showcasing his innovative approach to drug development.
Latest Patents
Katsuo Anma holds 2 patents related to the synthesis of 2,3-di-substituted-5,6-dihydroimidazo [2,1-b] thiazole and its salts. These compounds are characterized by their anti-carrageenin edema activity, making them useful as anti-inflammatory agents and immuno modulators. The patents detail the production process, which involves reacting specific amides with N,N'-ethylene thiourea to yield these valuable pharmaceutical compounds.
Career Highlights
Throughout his career, Katsuo Anma has worked with prominent companies in the pharmaceutical industry, including Toyo Jozo Co., Ltd. and Kumiai Chemical Industry Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug formulation and development.
Collaborations
Katsuo Anma has collaborated with several professionals in his field, including Kazuo Nishio and Isao Chiyomaru. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical compounds.
Conclusion
Katsuo Anma's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key figure in the industry. His work continues to impact the development of effective anti-inflammatory agents, showcasing the importance of innovation in healthcare.